Cargando…
m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway
BACKGROUND: Gemcitabine resistance has brought great challenges to the treatment of pancreatic cancer. The N6-methyladenosine (m6A) mutation has been shown to have a significant regulatory role in chemosensitivity; however, it is not apparent whether gemcitabine resistance can be regulated by fat ma...
Autores principales: | Lin, Kai, Zhou, Endi, Shi, Ting, Zhang, Siqing, Zhang, Jinfan, Zheng, Ziruo, Pan, Yuetian, Gao, Wentao, Yu, Yabin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464189/ https://www.ncbi.nlm.nih.gov/pubmed/37605223 http://dx.doi.org/10.1186/s13046-023-02792-0 |
Ejemplares similares
-
The m(6)A eraser FTO facilitates proliferation and migration of human cervical cancer cells
por: Zou, Dongling, et al.
Publicado: (2019) -
Correction to: The m(6)A eraser FTO facilitates proliferation and migration of human cervical cancer cells
por: Zou, Dongling, et al.
Publicado: (2020) -
Gene Polymorphisms of m6A Erasers FTO and ALKBH1 Associated with Susceptibility to Gastric Cancer
por: Li, Yue, et al.
Publicado: (2022) -
NEDD4 promotes cell growth and migration via PTEN/PI3K/AKT signaling in hepatocellular carcinoma
por: Huang, Zhi-Jun, et al.
Publicado: (2017) -
FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m(6)A methylation of TNIP1
por: Zhou, Chuandi, et al.
Publicado: (2023)